{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:34Z","timestamp":1785801634317,"version":"3.56.0"},"reference-count":100,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background\/Objectives: Recent advances in stroke genetics have substantially enhanced our understanding of the complex genetic architecture underlying cerebral infarction and other stroke subtypes. As knowledge in this field expands, healthcare providers must remain informed about these latest developments. This review aims to provide a comprehensive overview of recent advances in stroke genetics, with a focus on cerebral infarction, and discuss their potential impact on patient care and future research directions. Methods: We reviewed recent literature about advances in stroke genetics, focusing on cerebral infarction, and discussed their potential impact on patient care and future research directions. Key developments include the identification of monogenic stroke syndromes, such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, and cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy caused by mutations in the NOTCH3 and HTRA1 genes, respectively. In addition, the role of RNF213 in moyamoya disease and other cerebrovascular disorders, particularly in East Asian populations, has been elucidated. The development of polygenic risk scores for assessing genetic predisposition to stroke has demonstrated the potential to improve risk prediction beyond traditional factors. Genetic studies have also elucidated the distinct genetic architecture of stroke subtypes, including large artery atherosclerosis, small vessel disease, and cardioembolic stroke. Furthermore, the investigation of epigenetic modifications influencing stroke risk and its outcomes has revealed new research avenues, while advancements in pharmacogenomics highlight the potential for personalized stroke treatment based on individual genetic profiles. Conclusions: These genetic discoveries have important clinical implications, including improved risk stratification, targeted prevention strategies, and the development of novel therapeutic approaches.<\/jats:p>","DOI":"10.3390\/genes16010059","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T11:57:58Z","timestamp":1736164678000},"page":"59","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recent Advances in Stroke Genetics\u2014Unraveling the Complexity of Cerebral Infarction: A Brief Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3178-8171","authenticated-orcid":false,"given":"Takeshi","family":"Yoshimoto","sequence":"first","affiliation":[{"name":"Department of Stroke and Cerebrovascular Diseases, University of Tsukuba Hospital, Tsukuba 305-8576, Japan"},{"name":"Division of Stroke Prevention and Treatment, Institute of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamagami","sequence":"additional","affiliation":[{"name":"Division of Stroke Prevention and Treatment, Institute of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsumaru","sequence":"additional","affiliation":[{"name":"Department of Stroke and Cerebrovascular Diseases, University of Tsukuba Hospital, Tsukuba 305-8576, Japan"},{"name":"Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"ref_1","unstructured":"GBD 2019 Stroke Collaborators (2021). Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol., 20, 795\u2013820."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1253\/circj.CJ-17-0177","article-title":"Incidence, management and short-term outcome of stroke in a general population of 1.4 Million Japanese\u2014Shiga Stroke Registry","volume":"81","author":"Takashima","year":"2017","journal-title":"Circ. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1474-4422(12)70234-X","article-title":"Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): A meta-analysis of genome-wide association studies","volume":"11","author":"Traylor","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/STROKEAHA.113.002707","article-title":"Shared genetic susceptibility to ischemic stroke and coronary artery disease: A genome-wide analysis of common variants","volume":"45","author":"Dichgans","year":"2014","journal-title":"Stroke"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/STROKEAHA.119.024151","article-title":"Genetics of cerebral small vessel disease","volume":"51","author":"Marini","year":"2020","journal-title":"Stroke"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","article-title":"Stroke genetics informs drug discovery and risk prediction across ancestries","volume":"611","author":"Mishra","year":"2022","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1212\/WNL.0000000000006851","article-title":"Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting","volume":"92","author":"Chauhan","year":"2019","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.113.000390","article-title":"Genetics of Ischemic Stroke in Young Adults","volume":"7","author":"Cheng","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"eClinicalMedicine (2023). The rising global burden of stroke. eClinicalMedicine, 59.","DOI":"10.1016\/j.eclinm.2023.102028"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.neurobiolaging.2015.08.026","article-title":"Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer\u2019s disease","volume":"36","author":"Ryan","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","article-title":"Moyamoya disease: Diagnosis and interventions","volume":"21","author":"Ihara","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yoshimoto, T., Tanaka, K., Koge, J., Saito, S., Yamagami, H., Nakaoku, Y., Ogata, S., Nishimura, K., Yamaguchi, E., and Chiba, T. (2022). Impact of the RNF213 p.R4810K variant on endovascular therapy for large-vessel occlusion stroke. Stroke Vasc. Intervent. Neurol., 2.","DOI":"10.1161\/SVIN.122.000396"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, T., Guo, C., Liao, X., Xia, J., Wang, X.X., Deng, J., and Yan, J. (2017). Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis\/occlusion disease in a Chinese population. Environ. Health Prev. Med., 22.","DOI":"10.1186\/s12199-017-0649-0"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kim, J., Park, Y.S., Woo, M.H., An, H.J., Kim, J.O., Park, H.S., Ryu, C.S., Kim, O.J., and Kim, N.K. (2020). Distribution of intracranial major artery stenosis\/occlusion according to RNF213 polymorphisms. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061956"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1161\/STROKEAHA.112.663864","article-title":"Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis\/occlusion","volume":"43","author":"Miyawaki","year":"2012","journal-title":"Stroke"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3171\/2016.2.JNS152173","article-title":"RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance","volume":"126","author":"Zhang","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12199-015-0498-7","article-title":"A new horizon of moyamoya disease and its associated health risks was explored using RNF213","volume":"21","author":"Koizumi","year":"2016","journal-title":"Environ. Health Prev. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s10571-022-01315-3","article-title":"Monogenic causes in familial stroke across intracerebral hemorrhage and ischemic stroke subtypes identified by whole-exome sequencing","volume":"43","author":"Chang","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chojdak-\u0141ukasiewicz, J., Dziadkowiak, E., and Budrewicz, S. (2021). Monogenic causes of strokes. Genes, 12.","DOI":"10.3390\/genes12121855"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1474-4422(14)70029-8","article-title":"Current concepts and clinical applications of stroke genetics","volume":"13","author":"Falcone","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/383707a0","article-title":"Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia","volume":"383","author":"Joutel","year":"1996","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJMoa0801560","article-title":"Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease","volume":"360","author":"Hara","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.08.036","article-title":"Increased prevalence of cerebrovascular disease in hospitalized patients with Marfan syndrome","volume":"27","author":"Kim","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, K., Loong, S.S.E., Yuen, L.Z.H., Venketasubramanian, N., Chin, H.L., Lai, P.S., and Tan, B.Y.Q. (2023). Genetics in ischemic stroke: Current perspectives and future directions. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10120495"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/VHRM.S388257","article-title":"Cerebrovascular fibromuscular dysplasia\u2014A practical review","volume":"19","author":"Kesav","year":"2023","journal-title":"Vasc. Health Risk. Manag."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCULATIONAHA.118.038439","article-title":"Moyamoya disease susceptibility variant RNF213 p.R4810K increases the risk of ischemic stroke attributable to large-artery atherosclerosis","volume":"139","author":"Okazaki","year":"2019","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1161\/STROKEAHA.112.665760","article-title":"Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genome-wide associations","volume":"43","author":"Bevan","year":"2012","journal-title":"Stroke"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ana.25369","article-title":"Genome-wide meta-analysis identifies 3 novel loci associated with stroke","volume":"84","author":"Malik","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Abraham, G., Malik, R., Yonova-Doing, E., Salim, A., Wang, T., Danesh, J., Butterworth, A.S., Howson, J.M.M., Inouye, M., and Dichgans, M. (2019). Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke. Nat. Commun., 10.","DOI":"10.1038\/s41467-019-13848-1"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamaneurol.2015.0582","article-title":"Rare and coding region genetic variants associated with risk of ischemic stroke: The NHLBI Exome Sequence Project","volume":"72","author":"Auer","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00415-015-7794-4","article-title":"Monogenic causes of stroke: Now and the future","volume":"262","author":"Tan","year":"2015","journal-title":"J. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.02.019","article-title":"Characteristics of cerebral microbleeds in patients with Fabry disease","volume":"25","author":"Kono","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.045","article-title":"Prevalence of Fabry disease in young patients with stroke in Argentina","volume":"27","author":"Reisin","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.010","article-title":"Prevalence of Fabry disease in stroke patients\u2014A systematic review and meta-analysis","volume":"23","author":"Shi","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/neup.12607","article-title":"Cerebral small vessel disease with hemorrhagic stroke related to COL4A1 mutation: A case report","volume":"40","author":"Nandeesh","year":"2020","journal-title":"Neuropathology"},{"key":"ref_37","unstructured":"Plaisier, E., Ronco, P., Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). GeneReviews\u00ae [Internet], University of Washington."},{"key":"ref_38","first-page":"781","article-title":"A case of young adult presenting with cerebral infarction caused by homocystinuria","volume":"56","author":"Suzuki","year":"2004","journal-title":"No To Shinkei"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Homocysteine Studies Collaboration (2002). Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA, 288, 2015\u20132022.","DOI":"10.1001\/jama.288.16.2015"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0140-6736(99)90244-1","article-title":"Mitochondrial DNA and disease","volume":"354","author":"Chinnery","year":"1999","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/01.STR.27.8.1420","article-title":"Adult-onset MELAS. Evidence for involvement of neurons as well as cerebral vasculature in stroke-like episodes","volume":"27","author":"Gilchrist","year":"1996","journal-title":"Stroke"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/STROKEAHA.114.006735","article-title":"Shifting the CARASIL paradigm: Report of a non-Asian family and literature review","volume":"46","author":"Cordeiro","year":"2015","journal-title":"Stroke"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s00415-023-11590-9","article-title":"Pontine autosomal dominant microangiopathy with leukoencephalopathy: Col4A1 gene variants in the original family and sporadic stroke","volume":"270","author":"Roos","year":"2023","journal-title":"J. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"O\u2019Toole, G., Swan, D., Connors, J.M., and Thachil, J. (2024). Hematological causes of acute ischemic stroke in younger individuals. J. Thromb. Haemost., S1538-7836.","DOI":"10.1016\/j.jtha.2024.09.025"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"International Stroke Genetics Consortium (ISGC), Wellcome Trust Case Control Consortium 2 (WTCCC2), Bellenguez, C., Bevan, S., Gschwendtner, A., Spencer, C.C.A., Burgess, A.I., Pirinen, M., Jackson, C.A., and Traylor, M. (2012). Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat. Genet., 44, 328\u2013333.","DOI":"10.1038\/ng.1081"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Granata, A., Kasioulis, I., Serrano, F., Cooper, J.D., Traylor, M., Sinha, S., and Markus, H.S. (2022). The Histone Deacetylase 9 Stroke-Risk Variant Promotes Apoptosis and Inflammation in a Human iPSC-Derived Smooth Muscle Cells Model. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.849664"},{"key":"ref_47","first-page":"8650","article-title":"Genetic variant in ZFHX3 Geneon 16q22 associated with risk of stroke in Chinese Han population","volume":"9","author":"Xue","year":"2016","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Gittleman, H.R., Merkulova, A., Alhalabi, O., Stavrou, E.X., Veigl, M.L., Barnholtz-Sloan, J.S., and Schmaier, A.H. (2016). A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular Disease. Front. Med., 3.","DOI":"10.3389\/fmed.2016.00017"},{"key":"ref_49","first-page":"e1271","article-title":"Genome-wide association meta-analysis of functional outcome after ischemic stroke","volume":"92","author":"Pedersen","year":"2019","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: Current concepts and future perspectives","volume":"7","author":"Kuroda","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Liu, W., Morito, D., Takashima, S., Mineharu, Y., Kobayashi, H., Hitomi, T., Hashikata, H., Matsuura, N., Yamazaki, S., and Toyoda, A. (2011). Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022542"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada","year":"2011","journal-title":"J. Hum. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Yoshimoto, T., Ishiyama, H., Hattori, Y., Nishimura, K., Okada, Y., Watanabe, H., Ohyagi, Y., Akaiwa, Y., Miyamoto, T., and Kawamoto, M. (2023). Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke\/transient ischemic attack. Atherosclerosis, 382.","DOI":"10.1016\/j.atherosclerosis.2023.117281"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Eto, F., Yoshimoto, T., Okazaki, S., Nishimura, K., Ogura, S., Yamaguchi, E., Fukuma, K., Saito, S., Washida, K., and Koga, M. (2021). RNF213 p.R4810K (c.14429G > A) variant determines anatomical variations of the circle of Willis in cerebrovascular disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.681743"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000442298","article-title":"Research progresses in understanding the pathophysiology of Moyamoya disease","volume":"41","author":"Bersano","year":"2016","journal-title":"Cerebrovasc. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nri3477","article-title":"The role of dendritic cells in autoimmunity","volume":"13","author":"Ganguly","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Kanamori, F., Yokoyama, K., Ota, A., Yoshikawa, K., Karnan, S., Maruwaka, M., Shimizu, K., Ota, S., Uda, K., and Araki, Y. (2021). Transcriptome-wide analysis of intracranial artery in patients with moyamoya disease showing upregulation of immune response and downregulation of oxidative phosphorylation and DNA repair. Neurosurg. Focus, 51.","DOI":"10.3171\/2021.6.FOCUS20870"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.01627","article-title":"Moyamoya disease: Epidemiology, clinical features, and diagnosis","volume":"18","author":"Kim","year":"2016","journal-title":"J. Stroke."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hosoki, S., Yoshimoto, T., and Ihara, M. (2021). A case of hemichorea in RNF213-related vasculopathy. BMC Neurol., 21.","DOI":"10.1186\/s12883-021-02061-7"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Jang, M.A., Shin, S., Yoon, J.H., and Ki, C.S. (2015). Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1516 Korean individuals. BMC Med. Genet., 16.","DOI":"10.1186\/s12881-015-0252-4"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1212\/WNL.0000000000008901","article-title":"Predictive role of heterozygous p.R4810K of RNF213 in the phenotype of Chinese Moyamoya disease","volume":"94","author":"Wang","year":"2020","journal-title":"Neurology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.013","article-title":"RNF213 p.R4810K polymorphism and the risk of moyamoya disease, intracranial major artery stenosis\/occlusion, and quasi-Moyamoya disease: A meta-analysis","volume":"27","author":"Wang","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jnnp-2022-330542","article-title":"Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging","volume":"94","author":"Lu","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1552-6569.2008.00272.x","article-title":"Moyamoya phenomenon secondary to intracranial atherosclerotic disease: Diagnosis by 3T magnetic resonance imaging","volume":"19","author":"Ashley","year":"2009","journal-title":"J. Neuroimaging"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Yamaguchi, E., Yoshimoto, T., Ogura, S., Saito, K., Saito, S., Hattori, Y., Wasida, K., Nishimura, K., Toyoda, K., and Koga, M. (2022). Association of the RNF213 p.R4810K variant with the outer diameter of cervical arteries in patients with ischemic stroke. Stroke Vasc. Intervent. Neurol., 2.","DOI":"10.1161\/SVIN.121.000298"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacasi.2023.05.002","article-title":"RNF213 p.R4810K variant increases the risk of vasospastic angina","volume":"3","author":"Ishiyama","year":"2023","journal-title":"JACC Asia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41588-020-0705-3","article-title":"Population-specific and transancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease","volume":"52","author":"Koyama","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Morimoto, T., Mineharu, Y., Ono, K., Nakatochi, M., Ichihara, S., Kabata, R., Takagi, Y., Cao, Y., Zhao, L., and Kobayashi, H. (2017). Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175649"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Mineharu, Y., and Miyamoto, S. (2021). RNF213 and GUCY1A3 in Moyamoya disease: Key regulators of metabolism, inflammation, and vascular stability. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.687088"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.chest.2017.09.023","article-title":"Nonsyndromic peripheral pulmonary artery stenosis is associated with homozygosity of RNF213 p.Arg4810Lys regardless of co-occurrence of Moyamoya disease","volume":"153","author":"Chang","year":"2018","journal-title":"Chest"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.healun.2019.08.022","article-title":"Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension","volume":"39","author":"Hiraide","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Kobayashi, H., Kabata, R., Kinoshita, H., Morimoto, T., Ono, K., Takeda, M., Choi, J., Okuda, H., Liu, W., and Harada, K.H. (2018). Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice. Pulm. Circ., 8.","DOI":"10.1177\/2045894018778155"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e1783","DOI":"10.1212\/WNL.0000000000011653","article-title":"Association of de novo RNF213 variants with childhood onset Moyamoya disease and diffuse occlusive vasculopathy","volume":"96","author":"Pinard","year":"2021","journal-title":"Neurology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/svn-2022-002276","article-title":"Detailed phenotype of RNF213 p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack","volume":"8","author":"Zhou","year":"2023","journal-title":"Stroke Vasc. Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/ajmg.a.37829","article-title":"Homozygosity for moyamoya disease risk allele leads to moyamoya disease with extracranial systemic and pulmonary vasculopathy","volume":"170","author":"Fukushima","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Jee, T.K., Yeon, J.Y., Kim, S.M., Bang, O.Y., Kim, J.S., and Hong, S.C. (2020). Prospective screening of extracranial systemic arteriopathy in young adults with Moyamoya disease. J. Am. Heart Assoc., 9.","DOI":"10.1161\/JAHA.120.016670"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1212\/WNL.0000000000012263","article-title":"Development and validation of a polygenic risk score for stroke in the Chinese population","volume":"97","author":"Lu","year":"2021","journal-title":"Neurology"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Rutten-Jacobs, L.C., Larsson, S.C., Malik, R., Rannikm\u00e4e, K., MEGASTROKE consortium, International Stroke Genetics Consortium, Sudlow, C.L., Dichgans, M., Markus, H.S., and Traylor, M. (2018). Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: Cohort study of 306 473 UK Biobank participants. BMJ, 363.","DOI":"10.1136\/bmj.k4168"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.121.058426","article-title":"Predictive utility of a validated polygenic risk score for long-term risk of coronary heart disease in young and middle-aged adults","volume":"146","author":"Khan","year":"2022","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.0000000000000707","article-title":"Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12","volume":"83","author":"Kilarski","year":"2014","journal-title":"Neurology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ana.26332","article-title":"Genetic architecture of stroke of undetermined source: Overlap with known stroke etiologies and associations with modifiable risk factors","volume":"91","author":"Georgakis","year":"2022","journal-title":"Ann. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41431-020-0580-5","article-title":"Alternate approach to stroke phenotyping identifies a genetic risk locus for small vessel stroke","volume":"28","author":"McArdle","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/svn-2023-002428","article-title":"Associations of polygenic risk scores with risks of stroke and its subtypes in Chinese","volume":"9","author":"Yang","year":"2024","journal-title":"Stroke Vasc. Neurol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan, J.W., Shcherbina, A., Justesen, J.M., Turakhia, M., Perez, M., Wand, H., Tcheandjieu, C., Clarke, S.L., Rivas, M.A., and Ashley, E.A. (2021). Combining clinical and polygenic risk improves stroke prediction among individuals with atrial fibrillation. Circ. Genom. Precis. Med., 14.","DOI":"10.1161\/CIRCGEN.120.003168"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Kassis, H., Shehadah, A., Chopp, M., and Zhang, Z.G. (2017). Epigenetics in stroke recovery. Genes, 8.","DOI":"10.3390\/genes8030089"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Peng, J., Ghosh, D., Zhang, F., Yang, L., Wu, J., Pang, J., Zhang, L., Yin, S., and Jiang, Y. (2022). Advancement of epigenetics in stroke. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.981726"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1177\/0271678X221116192","article-title":"Epigenetic mechanisms and potential therapeutic targets in stroke","volume":"42","author":"Chokkalla","year":"2022","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Balado, J., Fern\u00e1ndez-P\u00e9rez, I., Gallego-F\u00e1brega, C., Lazcano, U., Soriano-T\u00e1rraga, C., Vallverd\u00fa-Prats, M., Mola-Caminal, M., Rey-\u00c1lvarez, L., Macias-G\u00f3mez, A., and Su\u00e1rez-P\u00e9rez, A. (2024). DNA methylation and stroke prognosis: An epigenome-wide association study. Clin. Epigenetics, 16.","DOI":"10.1186\/s13148-024-01690-2"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Phillips, C.M., Stamatovic, S.M., Keep, R.F., and Andjelkovic, A.V. (2023). Epigenetics and stroke: Role of DNA methylation and effect of aging on blood-brain barrier recovery. Fluids Barriers CNS, 20.","DOI":"10.1186\/s12987-023-00414-7"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/STROKEAHA.122.037717","article-title":"Pharmacogenomics in stroke and cardiovascular disease: State of the art","volume":"54","author":"Ross","year":"2023","journal-title":"Stroke"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrneurol.2011.80","article-title":"Genetic susceptibility to ischemic stroke","volume":"7","author":"Meschia","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: A systematic review and meta-analysis","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/aps.2016.41","article-title":"Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke","volume":"37","author":"Liu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1159\/000445654","article-title":"Gene polymorphisms affect the effectiveness of atorvastatin in treating ischemic stroke patients","volume":"39","author":"Yue","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Bauer, T., Bouman, H.J., van Werkum, J.W., Ford, N.F., ten Berg, J.M., and Taubert, D. (2011). Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: Systematic review and meta-analysis. BMJ, 343.","DOI":"10.1136\/bmj.d4588"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1212\/WNL.0000000000201454","article-title":"Ticagrelor aspirin vs clopidogrel aspirin in CYP2C19 loss-of-function carriers with minor stroke or TIA stratified by risk profile","volume":"100","author":"Wang","year":"2023","journal-title":"Neurology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5551\/jat.63369","article-title":"P2Y12 reaction units and clinical outcomes in acute large artery atherosclerotic stroke: A multicenter prospective study","volume":"30","author":"Fukuma","year":"2023","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","article-title":"A pharmacogenetic versus a clinical algorithm for warfarin dosing","volume":"369","author":"Kimmel","year":"2013","journal-title":"N. Engl. J. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/1\/59\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:23:53Z","timestamp":1759919033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/1\/59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["genes16010059"],"URL":"https:\/\/doi.org\/10.3390\/genes16010059","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]}}}